Transthoracic echocardiography guided running of veno arterial extracorporeal membranous oxygenation in cardiogenic shock / Mohamed Ahmed Abouelwafa ; Supervised Waheed Radwan , Akram Abdelbary , Mohamed Khaled
Material type:
- الموجات فوق الصوتية فى مرضى هبوط عضلة القلب الحاد المدعومين بالضخ الوريدى الشريانى بإستخدام جهاز الأكسدة الغشائى [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.09.Ph.D.2017.Ma.T (Browse shelf(Opens below)) | Not for loan | 01010110074872000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.09.Ph.D.2017.Ma.T (Browse shelf(Opens below)) | 74872.CD | Not for loan | 01020110074872000 |
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Critical Care Medicine
Introduction. Cardiogenic shock is a physiologic state in which end-organ tissue hypoperfusion is a result of cardiac dysfunction. Mechanical circulatory support devices can provide cardiovascular support without worsening myocardial ischemia and may also decrease myocardial oxygen demand. (VA ECMO) support is increasingly being used in such patients, and echocardiography plays an important role in the management of these patients Aim of study: Detect the ability to introduce (VA ECMO) as temporary extracorporeal life support system (ECLS) in our unit. And to Demonstrate the role of IABP and ECMO in cardiogenic shock. Methods. Our study enrolled 21 patients supported by IABP counterpulsation and 7 patients supported by VA ECMO. Results. Our study showed no statistically significant difference in patients before and after initiation of IABP support regarding MAP [60±15 and 65.1±18.9, P value 0.129], and base deficit [-12.9±4.7 and -12.5±5.3, P value 0.332]. Our study showed statistically significant difference in patients before and after initiation of VA ECMO support regarding MAP [42.6±9.7 and 57.9 ±7.6, P value 0.005], and base deficit [-10.6 ±4.2 and -6.3 ±7.4, P value 0.038].Mortality was 76% in IABP group and 100% in VA ECMO group
Issued also as CD
There are no comments on this title.